Tian An Medicare Limited (HKG:0383)
Hong Kong · Delayed Price · Currency is HKD 1.040
0.00 (0.00%)
At close: Mar 27, 2026
Tian An Medicare Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,638 | 1,627 | 1,569 | 1,438 | 1,463 |
Other Revenue | - | - | - | 0.02 | 0.02 |
| 1,638 | 1,627 | 1,569 | 1,438 | 1,463 | |
Revenue Growth (YoY) | 0.68% | 3.72% | 9.11% | -1.75% | 22.56% |
Cost of Revenue | 1,363 | 1,305 | 1,287 | 1,184 | 1,203 |
Gross Profit | 275.37 | 322.65 | 282.23 | 253.7 | 260.23 |
Selling, General & Admin | 230.95 | 230.55 | 235.47 | 259.25 | 225.43 |
Other Operating Expenses | -26.02 | -13.14 | -23.56 | 19.31 | 46.49 |
Operating Expenses | 212.05 | 217.41 | 211.91 | 278.56 | 271.92 |
Operating Income | 63.31 | 105.23 | 70.33 | -24.86 | -11.69 |
Interest Expense | -22.37 | -29.11 | -47.81 | -59.02 | -58.25 |
Interest & Investment Income | 21.8 | 32.5 | 24.47 | 3.96 | 1.42 |
Currency Exchange Gain (Loss) | 8.13 | -15.24 | -0.62 | -15.65 | -6.01 |
EBT Excluding Unusual Items | 70.87 | 93.37 | 46.36 | -95.57 | -74.53 |
Impairment of Goodwill | - | - | - | - | -34.04 |
Gain (Loss) on Sale of Investments | 4.23 | -1.67 | -0.64 | -2.7 | -4.78 |
Gain (Loss) on Sale of Assets | - | - | - | -0.47 | 0.02 |
Asset Writedown | -75.57 | -34.69 | -4.92 | -23.95 | 2.29 |
Other Unusual Items | - | - | - | 5.52 | 0.58 |
Pretax Income | -0.47 | 57 | 40.81 | -117.17 | -110.47 |
Income Tax Expense | 20.34 | 15.03 | 14.91 | 1.98 | 16.8 |
Earnings From Continuing Operations | -20.81 | 41.98 | 25.89 | -119.15 | -127.27 |
Minority Interest in Earnings | -6.01 | -13.2 | -11.22 | -4.43 | -10.03 |
Net Income | -26.82 | 28.77 | 14.68 | -123.57 | -137.3 |
Net Income to Common | -26.82 | 28.77 | 14.68 | -123.57 | -137.3 |
Net Income Growth | - | 96.03% | - | - | - |
Shares Outstanding (Basic) | 1,083 | 1,086 | 924 | 724 | 724 |
Shares Outstanding (Diluted) | 1,083 | 1,086 | 924 | 724 | 724 |
Shares Change (YoY) | -0.26% | 17.55% | 27.60% | - | - |
EPS (Basic) | -0.02 | 0.03 | 0.02 | -0.17 | -0.19 |
EPS (Diluted) | -0.02 | 0.03 | 0.02 | -0.17 | -0.19 |
EPS Growth | - | 66.75% | - | - | - |
Free Cash Flow | - | -86.91 | 160.3 | -67.53 | 64.95 |
Free Cash Flow Per Share | - | -0.08 | 0.17 | -0.09 | 0.09 |
Dividend Per Share | - | 0.020 | 0.010 | - | - |
Dividend Growth | - | 100.00% | - | - | - |
Gross Margin | 16.81% | 19.83% | 17.99% | 17.64% | 17.78% |
Operating Margin | 3.86% | 6.47% | 4.48% | -1.73% | -0.80% |
Profit Margin | -1.64% | 1.77% | 0.94% | -8.59% | -9.38% |
Free Cash Flow Margin | - | -5.34% | 10.22% | -4.70% | 4.44% |
EBITDA | 154.71 | 196.63 | 154.02 | 69.43 | 86.73 |
EBITDA Margin | 9.44% | 12.08% | 9.82% | 4.83% | 5.93% |
D&A For EBITDA | 91.4 | 91.4 | 83.69 | 94.29 | 98.42 |
EBIT | 63.31 | 105.23 | 70.33 | -24.86 | -11.69 |
EBIT Margin | 3.86% | 6.47% | 4.48% | -1.73% | -0.80% |
Effective Tax Rate | - | 26.36% | 36.55% | - | - |
Revenue as Reported | 1,638 | 1,627 | 1,569 | 1,438 | 1,463 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.